Given the two previous cases, the author established that NUP98-RARG AML is sensitive to the standard 3+7 regimen, and that allogeneic HSC transplantation (allo-HSCT) may be the best procedure to achieve CR. This evidence concerns the gene NUP98 and acute myeloid leukemia.